LAURUS LABS
Quarterly Results Analysis [Dec2024]
LAURUS LABS Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹1,415 Cr | ₹1,224 Cr | ₹1,195 Cr | ₹1,440 Cr | ₹1,195 Cr | ₹1,224 Cr | ₹1,182 Cr | ₹1,381 Cr |
Expenses | ₹1,130 Cr | ₹1,045 Cr | ₹1,024 Cr | ₹1,198 Cr | ₹1,014 Cr | ₹1,037 Cr | ₹1,015 Cr | ₹1,095 Cr |
Operating Income | ₹285 Cr | ₹178 Cr | ₹171 Cr | ₹241 Cr | ₹181 Cr | ₹188 Cr | ₹167 Cr | ₹286 Cr |
Other Income | ₹9 Cr | ₹5 Cr | ₹3 Cr | ₹19 Cr | ₹2 Cr | ₹2 Cr | ₹4 Cr | ₹2 Cr |
Interest | ₹58 Cr | ₹53 Cr | ₹49 Cr | ₹51 Cr | ₹51 Cr | ₹42 Cr | ₹39 Cr | ₹53 Cr |
Depreciation | ₹106 Cr | ₹108 Cr | ₹106 Cr | ₹102 Cr | ₹98 Cr | ₹93 Cr | ₹91 Cr | ₹87 Cr |
Profit Before Tax | ₹131 Cr | ₹23 Cr | ₹18 Cr | ₹107 Cr | ₹35 Cr | ₹54 Cr | ₹41 Cr | ₹147 Cr |
Profit After Tax | ₹91 Cr | ₹18 Cr | ₹12 Cr | ₹75 Cr | ₹25 Cr | ₹39 Cr | ₹28 Cr | ₹107 Cr |
EPS | ₹1.71 | ₹0.37 | ₹0.23 | ₹1.40 | ₹0.43 | ₹0.69 | ₹0.46 | ₹1.91 |
Industry Peers & Returns | 1W | 1M | 1Y |
LAURUS LABS | -2.2% | -4.4% | 45.8% |
SUN PHARMACEUTICAL INDUSTRIES | -4.2% | -7.7% | 24.1% |
CIPLA | 3.3% | -4.8% | 6.5% |
DR REDDYS LABORATORIES | -2.4% | -12.8% | 1.1% |
ZYDUS LIFESCIENCES | -0.3% | -2.1% | 24.5% |
DIVIS LABORATORIES | -0.6% | -5.6% | 57.5% |
MANKIND PHARMA | -0.7% | -13.8% | 18.2% |
TORRENT PHARMACEUTICALS | 3.4% | -1.7% | 37.7% |
LUPIN | -3.2% | -12.7% | 39.3% |
LAURUS LABS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 15.64 % |
Y-o-Y | 18.42 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹1,415 Cr | 15.64 | |
Sep2024 | ₹1,224 Cr | 2.41 | |
Jun2024 | ₹1,195 Cr | -17.00 | |
Mar2024 | ₹1,440 Cr | 20.48 | |
Dec2023 | ₹1,195 Cr | -2.41 | |
Sep2023 | ₹1,224 Cr | 3.61 | |
Jun2023 | ₹1,182 Cr | -14.42 | |
Mar2023 | ₹1,381 Cr | - |
LAURUS LABS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 59.90 % |
Y-o-Y | 57.18 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹285 Cr | 59.90 | |
Sep2024 | ₹178 Cr | 4.16 | |
Jun2024 | ₹171 Cr | -29.11 | |
Mar2024 | ₹241 Cr | 33.11 | |
Dec2023 | ₹181 Cr | -3.43 | |
Sep2023 | ₹188 Cr | 12.69 | |
Jun2023 | ₹167 Cr | -41.61 | |
Mar2023 | ₹286 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 38.30 % |
Y-o-Y | 32.74 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 20.15% | 38.30 | |
Sep2024 | 14.57% | 1.67 | |
Jun2024 | 14.33% | -14.55 | |
Mar2024 | 16.77% | 10.47 | |
Dec2023 | 15.18% | -1.04 | |
Sep2023 | 15.34% | 8.72 | |
Jun2023 | 14.11% | -31.77 | |
Mar2023 | 20.68% | - |
LAURUS LABS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 411.34 % |
Y-o-Y | 259.99 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹91 Cr | 411.34 | |
Sep2024 | ₹18 Cr | 45.13 | |
Jun2024 | ₹12 Cr | -83.79 | |
Mar2024 | ₹75 Cr | 199.25 | |
Dec2023 | ₹25 Cr | -35.99 | |
Sep2023 | ₹39 Cr | 38.45 | |
Jun2023 | ₹28 Cr | -73.52 | |
Mar2023 | ₹107 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 341.38 % |
Y-o-Y | 203.32 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 6.4 % | 341.38 | |
Sep2024 | 1.45 % | 42.16 | |
Jun2024 | 1.02 % | -80.50 | |
Mar2024 | 5.23 % | 147.87 | |
Dec2023 | 2.11 % | -34.27 | |
Sep2023 | 3.21 % | 33.75 | |
Jun2023 | 2.4 % | -69.11 | |
Mar2023 | 7.77 % | - |
LAURUS LABS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 362.16 % |
Y-o-Y | 297.67 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹1.71 | 362.16 | |
Sep2024 | ₹0.37 | 60.87 | |
Jun2024 | ₹0.23 | -83.57 | |
Mar2024 | ₹1.4 | 225.58 | |
Dec2023 | ₹0.43 | -37.68 | |
Sep2023 | ₹0.69 | 50.00 | |
Jun2023 | ₹0.46 | -75.92 | |
Mar2023 | ₹1.91 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD